Blog Home


HA Web First: Improved Prescribing And Reimbursement Practices In China

February 26th, 2014

Pay-for-performance—reimbursing health care providers based on the results they achieved with their patients as a way to improve quality and efficiency—has become a major component of health reforms in the United States, the United Kingdom, and other affluent countries. Although the approach has also become popular in the developing world, there has been little evaluation of its impact. A new study, released today as a Web First by Health Affairs, examines the effects of pay-for-performance, combined with capitation, in China’s largely rural Ningxia Province.

Between 2009 and 2012, authors Winnie Yip, Timothy Powell-Jackson, Wen Chen, Min Hu, Eduardo Fe, Mu Hu, Weiyan Jian, Ming Lu, Wei Han, and William C. Hsiao, in collaboration with the provincial government, conducted a matched-pair, cluster-randomized experiment to review that province’s primary care providers’ antibiotic prescribing practices, health spending, and several other factors. They found a near-15 percent reduction in antibiotic prescriptions and a small decline in total spending per visit to community clinics.

The authors note that the success of this experiment has motivated the government of Ningxia Province to expand this intervention to the entire province. “From a policy perspective, our study offers several additional valuable lessons,” they conclude. “Provider patterns of overprescribing and inappropriate prescribing cannot be changed overnight; nor can patient demand, for which antibiotics are synonymous with quality care. Provider payment reform probably needs to be accompanied by training for providers and health education for patients.”

Yip, Fe, and Han are affiliated with the Blavatnik School of Government, University of Oxford in Britain; Powell-Jackson is at the London School of Hygiene and Tropical Medicine; Chen and Min Hu are affiliated with Fudan University in Shanghai; Mu Hu, Jian, and Lu are with Peking University Health Science Center in Beijing; and Hsiao is affiliated at the Harvard School of Public Health in Boston.

The study, which was funded by the Bill & Melinda Gates Foundation and a European Commission Seventh Framework Programme research grant, will also appear in the March issue of Health Affairs.

Email This Post Email This Post Print This Post Print This Post

 to the #1 source of health policy research.

No Trackbacks for “HA Web First: Improved Prescribing And Reimbursement Practices In China”

2 Responses to “HA Web First: Improved Prescribing And Reimbursement Practices In China”

  1. John Barnett Says:

    Doctors in China make a good part of their salary from selling prescription drugs, so any policy that tries to get rid of this conflict of interest should help. Seems like a step in the right direction, but agree that it is hard to quantify it.

  2. Michael Kleinrock Says:

    The reduction in antibiotic prescribing coincides with a national program to reduce this dangerous practice, with similar overall reductions in antibiotic usage. It’s hard to read much into the study findings with that bit removed. A much less dramatic finding in my view. Still, it is interesting to study and measure programs to change medical practice and I applaud the effort, though it appears the results have been modest.

Leave a Reply

Comment moderation is in use. Please do not submit your comment twice -- it will appear shortly.

Authors: Click here to submit a post.